Baktavachalam Gajendra B, Delaney Bryan, Fisher Tracey L, Ladics Gregory S, Layton Raymond J, Locke Mary Eh, Schmidt Jean, Anderson Jennifer A, Weber Natalie N, Herman Rod A, Evans Steven L
a E. I. DuPont India Private Limited ; Hyderabad , Telangana , India.
GM Crops Food. 2015;6(2):80-102. doi: 10.1080/21645698.2015.1054093.
Maize (Zea mays) is a widely cultivated cereal that has been safely consumed by humans and animals for centuries. Transgenic or genetically engineered insect-resistant and herbicide-tolerant maize, are commercially grown on a broad scale. Event TC1507 (OECD unique identifier: DAS-Ø15Ø7-1) or the Herculex®(#) I trait, an insect-resistant and herbicide-tolerant maize expressing Cry1F and PAT proteins, has been registered for commercial cultivation in the US since 2001. A science-based safety assessment was conducted on TC1507 prior to commercialization. The safety assessment addressed allergenicity; acute oral toxicity; subchronic toxicity; substantial equivalence with conventional comparators, as well as environmental impact. Results from biochemical, physicochemical, and in silico investigations supported the conclusion that Cry1F and PAT proteins are unlikely to be either allergenic or toxic to humans. Also, findings from toxicological and animal feeding studies supported that maize with TC1507 is as safe and nutritious as conventional maize. Maize with TC1507 is not expected to behave differently than conventional maize in terms of its potential for invasiveness, gene flow to wild and weedy relatives, or impact on non-target organisms. These safety conclusions regarding TC1507 were acknowledged by over 20 regulatory agencies including United States Environment Protection Agency (US EPA), US Department of Agriculture (USDA), Canadian Food Inspection Agency (CFIA), and European Food Safety Authority (EFSA) before authorizing cultivation and/or food and feed uses. A comprehensive review of the safety studies on TC1507, as well as some benefits, are presented here to serve as a reference for regulatory agencies and decision makers in other countries where authorization of TC1507 is or will be pursued.
玉米(Zea mays)是一种广泛种植的谷物,几个世纪以来一直被人类和动物安全食用。转基因或基因工程抗虫耐除草剂玉米已广泛商业化种植。事件TC1507(经合组织唯一标识符:DAS-Ø15Ø7-1)或Herculex®(#)I性状,即一种表达Cry1F和PAT蛋白的抗虫耐除草剂玉米,自2001年起已在美国注册用于商业种植。在商业化之前,对TC1507进行了基于科学的安全性评估。该安全性评估涉及致敏性、急性经口毒性、亚慢性毒性、与传统对照物的实质等同性以及环境影响。生物化学、物理化学和计算机模拟研究的结果支持以下结论:Cry1F和PAT蛋白对人类不太可能具有致敏性或毒性。此外,毒理学和动物喂养研究的结果支持含有TC1507的玉米与传统玉米一样安全且营养丰富。预计含有TC1507的玉米在入侵性、基因向野生和杂草近缘种的流动或对非靶标生物的影响方面与传统玉米没有不同表现。在授权种植和/或食品及饲料用途之前,包括美国环境保护局(US EPA)、美国农业部(USDA)、加拿大食品检验局(CFIA)和欧洲食品安全局(EFSA)在内的20多个监管机构认可了这些关于TC1507的安全结论。本文介绍了对TC1507安全性研究的全面综述以及一些益处,以供其他正在或将要寻求授权TC1507的国家的监管机构和决策者参考。